Observed Signal · Sep 7, 2026 · Strategy · Source: Modern Retail · Impact: 2/5 · Sentiment: Positive

Brands Use Clinical Research as Growth Engine

Executive Signal Summary

Supplement and cleaning brands like AG1, Ritual, and Blueland are increasingly funding their own clinical research to differentiate products, boost advertising performance, and gain retail shelf space. These companies conduct or commission studies published in peer-reviewed journals, using findings to support marketing claims and product development. For instance, AG1 committed $20 million to research, while Ritual has invested over $5 million in studies. Such research helps brands combat misinformation, appeal to data-driven consumers, and satisfy wholesale buyers demanding third-party validation. Although there is no official FTC definition of 'clinical,' companies follow guidelines requiring competent scientific evidence for health claims. This strategy serves as a long-term brand investment, with executives noting higher-performing ads and stronger retail positioning as outcomes.

Polaris7 AgentPolaris7 Strategic Assessment
High Confidence

Highlights a growing trend among consumer brands to use clinical research for differentiation, but is not directly related to AdTech or MarTech infrastructure.

MARKET SIGNALS

Track AG1 Signals & Strategic Shifts

Polaris7 connects regulatory filings, primary sources, leadership changes, and M&A activity into structured intelligence. Set up your Polaris7 workspace to monitor relevant companies in your executive briefing.

  • Verified primary sources
  • Automated briefings
  • Instant watchlist setup

Key Takeaways & Evidence Grounding

  • AG1 committed $20 million to support three years of gut health and nutrient gap research.
  • Ritual has invested at least $5 million in clinical studies and employed up to 20 full-time positions for research.
  • Ritual completed at least five clinical studies, three peer-reviewed and published.
  • Blueland commissioned a study on PVA microplastics published in an international journal.
  • A 2024 Citruslabs survey found 85% of consumers are influenced by scientific claims.

Connected Companies & Entities

Ontology Mapping & Concepts

Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: Modern Retail•Published: Sep 7, 2026
Original Coverage Title: “How clinical research is being used as a growth engine”

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

Marketing StrategyOct 6, 2026

Consumer Healthcare Brands Embrace CPG Media Strategies

Consumer healthcare brands are increasingly adopting CPG-style media strategies to adapt to shifting consumer behavior and regulatory changes favoring OTC drugs. OTC sales rose to $58.2 billion in 2025, and the FDA has signaled openness to more prescription-to-OTC switches. Opella, spun out of Sanofi, exemplifies this trend, investing heavily in retail media, creator marketing, paid social, and search, with 60% of media investments now in digital channels. The company has built an 85-person in-house team using generative AI for creative production and brought programmatic and search in-house to boost ROI. Other companies like Kenvue and Hims & Hers are also adopting similar approaches. The shift brings challenges, including navigating retail media frictions and balancing long-term brand building with measurable performance, a balancing act CPG marketers already struggle with. AI search is also emerging as a key gateway to health information, requiring brands to monitor LLM citations.

Read assessment
Brand Strategy & DesignJun 5, 2026

Brand Expression Differentiates Brands in Age of AI

Adweek publishes an interview with Deena Bahri, CMO of Nutrafol, arguing that brand expression and creative positioning are the primary differentiators as AI levels access to performance marketing tools. Bahri describes her path from customer to CMO, Nutrafol’s move from fear-based to empowerment-driven messaging, and the company’s investments in clinical validation and transparency (including more than 25 clinical studies, NSF Sport Certification, and hiring a chief medical officer). The piece advises marketers to shift from lower-funnel performance tactics to full-funnel brand building and to use scientific credibility and authentic voice to build long-term trust and subscription-led lifetime value. Published by Adweek on 2026-06-05.

Read assessment
Product & Platform LaunchAug 25, 2026

BrandRank.AI Launches Brand Risk Monitor to Trace Unfavorable AI Answers Back to Their Sources

BrandRank.AI announced the launch of Brand Risk Monitor, a source-level intelligence capability that traces unfavorable AI answers back to government, regulatory, news and independent sources. The platform introduces a Venom Score to measure claim severity and propagation likelihood, along with a Composite Risk Score, seven damage categories, source-level evidence trails and signal-decay intelligence. The capability is available now within the BrandRank.AI platform.

Read assessment

WATCHLIST & BRIEFINGS

Receive future signals for AG1 & competitors in your briefing

Stay ahead of material M&A deals, leadership changes, account wins, and product rollouts. Polaris7 connects primary filings, company newsrooms, and trade reporting directly into your executive briefing.

  • Regular primary-source checks
  • Structured Watchlist briefings
  • Preserves current context